CNR2 and colitis: For the 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced model of acute colitis in rats, treatment with delta-9-tetrahydrocannabinol (THC) and the CB2 agonist AM 630 suppressed inflammation and reduced expression of CB2 receptor mRNA [22,32].